Bioprocess validation has the critical four virology expertise: large-scale eukaryotic cell culture, virus production and purification, and electron microscopy services. These integrated technical features help manufacturers perform virus detection and centrifugation and detect and quantify viruses by electron microscopy.
This report contains market size and forecasts of Bioprocess Validation in Global, including the following market information:
Global Bioprocess Validation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bioprocess Validation market was valued at 156.6 million in 2021 and is projected to reach US$ 267.4 million by 2028, at a CAGR of 7.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Extractables and Leachables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bioprocess Validation include Merck KGaA, SGS S.A., Eurofins Scientific, Sartorius AG, Pall Corporation, Cobetter Filtration Equipments Co., Ltd., Toxikon Corporation, DOC S.r.l. and MEISSNER FILTRATION PRODUCTS, INC. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioprocess Validation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioprocess Validation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bioprocess Validation Market Segment Percentages, by Type, 2021 (%)
Extractables and Leachables
Integrity Testing
Microbiology Testing
Global Bioprocess Validation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bioprocess Validation Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Companies
Biotechnology Companies
Contract Development and Manufacturing Organizations
Others
Global Bioprocess Validation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bioprocess Validation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bioprocess Validation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bioprocess Validation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
SGS S.A.
Eurofins Scientific
Sartorius AG
Pall Corporation
Cobetter Filtration Equipments Co., Ltd.
Toxikon Corporation
DOC S.r.l.
MEISSNER FILTRATION PRODUCTS, INC.
Thermo Fisher Scientific